|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Sorrento Therapeutics, Inc.
| | | Phone: | (858) 210-3700 | Fax: | (858) 210-3759 | Year Established: | 2006 | Ticker: | SRNE | Exchange: | NASDAQ | Main Contact: | Henry Ji, Ph.D., Co-Founder, President & CEO | | Other Contacts: | Jerome Zeldis, M.D., Ph.D.,, CMO Jeffrey Su, Ph.D., Executive VP & COO Kevin Herde, Executive VP & CFO Miranda Toledano, Executive VP, Corporate Development George Ng, J.D., Executive VP & Chief Administrative Officer
| | Company Description | Sorrento is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead product candidates include oncolytic immunotherapies and cellular therapies for oncology and hematological malignancies. | |
|
|
|
|
|